• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
228.84
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

cummins india ltd
Endurance Technologies consolidated net profit rises 12.78% in the March 2026 quarter
May 15,2026
Net profit of Endurance Technologies rose 12.78% to Rs 276.45 crore in the quarter ended March 2026 as against Rs 245.13 crore during the previous quarter ended March 2025. Sales rose 37.88% to Rs 4085.95 crore in the quarter ended March 2026 as against Rs 2963.48 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.79% to Rs 951.71 crore in the year ended March 2026 as against Rs 836.35 crore during the previous year ended March 2025. Sales rose 26.25% to Rs 14595.88 crore in the year ended March 2026 as against Rs 11560.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4085.952963.48 38 14595.8811560.81 26
OPM %13.9014.26 -13.4713.42 -
PBDT582.57444.61 31 2032.251621.24 25
PBT370.71302.20 23 1298.031082.53 20
NP276.45245.13 13 951.71836.35 14